Dossier
multi-cancer early detection
Coverage of multi-cancer early detection in the Nexus archive.
Sabrina Wright-Hobartperson1American Cancer Society Cancer Action Networkorganization1Chinelo Tylerperson1Mark Andersonperson1Ember Centerorganization1Colorado State Capitolplace1Washington, D.C.place1Grailorganization1U.K. National Health Serviceorganization1Galleri MCED testtopic1Charles Swantonperson1Francis Crick Instituteorganization1American Society of Clinical Oncologyorganization1
- Denver7 Everyday Hero uses her cancer diagnosis to push for change
Sabrina Wright-Hobart, a Colorado volunteer with the American Cancer Society Cancer Action Network, advocates for cancer patients and survivors using her personal experience with breast cancer and Stage 4 cancer diagnosis. She organizes legislative efforts, including multi-cancer early detection advocacy, and collaborates with lawmakers to improve access to care and research funding.
- Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story
A randomized trial of Grail’s Galleri multi-cancer early detection test, conducted with the U.K. National Health Service, showed no reduction in stage 3 and 4 cancers as its primary endpoint. An oncologist highlights additional context despite the negative trial results.